Surgeons who use a biologic scaffold are achieving higher success rates while still preserving the joint.1,2
Many surgeons and their patients would prefer rotator cuff repair over joint replacement. However, massive cuff tears have high failure rates. Tissue quality, biomechanical forces, and lack of a good vascular supply1-4 have led to reported failure rates of as high as 68%3 in large to massive tears (Grades III and IV).
Since poor tissue quality is a big obstacle to a successful repair, by augmenting the tissue with an ECM scaffold like Allopatch HD®, peer reviewed research has shown that surgeons can potentially go from a 40%1 success rate without augmentation to an 85.7%2 success rate with augmentation.
Clinical studies have shown that ECMs like Allopatch HD® are stronger, exhibiting better suture retention and greater ultimate load failure rates than synthetics and xenografts.4 In addition, Allopatch HD® requires no refrigeration or rehydration and is ready to use off the shelf almost immediately. It's minimally processed and not crosslinked, which better preserves and maintains the graft’s natural biomechanical, biochemical, and matrix properties.
Allopatch HD® Acellular Human Dermis
Your “no refrigeration, no hydration” scaffold solution
Y-Knot® PRO RC Self-Punching All-Suture Anchor
Our most popular anchor, made even simpler with cleatless technology
Solutions for Shoulder
1 Barber FA, Burns JP, Deutsch A, Labbé MR, Litchfield RB.. A prospective, randomized evaluation of acellular human dermal matrix augmentation for arthroscopic rotator cuff repair. Arthroscopy. 2012 Jan;28(1):8-15. doi: 10.1016/j.arthro.2011.06.038. Epub 2011 Oct 5.
2 Agrawal, V. Healing rates for challenging rotator cuff tears utilizing an acellular human dermal reinforcement graft.Int J Shoulder Surg. 2012 Apr;6(2):36-44. doi: 10.4103/0973-6042.96992.
3 Jost B, Pfirrmann CWA, Gerber C. Clinical outcome after structural failure of rotator cuff repairs. J Bone Joint Surg Am 2000; 82:304-14.)
4 Barber, FA, Aziz-Jacobo J. Biomechanical testing of commercially available soft-tissue augmentation materials. Arthroscopy
2009;25:1233-1239.